Fermenta Biotech Profile
Key Indicators
- Authorised Capital ₹ 31.83 Cr
as on 24-10-2024
- Paid Up Capital ₹ 14.72 Cr
as on 24-10-2024
- Company Age 73 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 359.21 Cr
as on 24-10-2024
- Satisfied Charges ₹ 309.97 Cr
as on 24-10-2024
- Revenue -14.92%
(FY 2023)
- Profit -290.27%
(FY 2023)
- Ebitda -48.91%
(FY 2023)
- Net Worth -15.63%
(FY 2023)
- Total Assets -6.73%
(FY 2023)
About Fermenta Biotech
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 506414.
The Corporate was formerly known as International Franchises Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 31.83 Cr and a paid-up capital of Rs 14.72 Cr.
The company currently has active open charges totaling ₹359.21 Cr. The company has closed loans amounting to ₹309.97 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Fermenta Biotech Limited India are Sumesh Gandhi as CFO and Varadvinayak Khambete as Company Secretary. Krishna Vasantkumar, Satish Nadimpally, Rajeshwari Datla, and Five other members serve as directors at the Company.
- CIN/LLPIN
L99999MH1951PLC008485
- Company No.
008485
- Stock Symbol
BSE : 506414
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 May 1951
- Date of AGM
12 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Fermenta Biotech?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prashant Nagre  | Managing Director | 06-May-2021 | Current |
| Sumesh Gandhi | CFO | 16-Feb-2017 | Current |
| Varadvinayak Khambete | Company Secretary | 30-Jul-2024 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pramod Kasat | Director | 30-May-2022 | Current |
| Krishna Vasantkumar | Whole-Time Director | 09-May-2010 | Current |
| Satish Nadimpally | Whole-Time Director | 01-Jul-2003 | Current |
| Rajeshwari Datla | Director | 21-Jul-2005 | Current |
| Pradeep Chandan | Director | 06-Mar-2024 | Current |
| Anupama Desai | Whole-Time Director | 27-Sep-2019 | Current |
Financial Performance and Corporate Structure Insights of Fermenta Biotech.
Fermenta Biotech Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.92% decrease. The company also saw a substantial fall in profitability, with a 290.27% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fermenta Biotech?
In 2023, Fermenta Biotech had a promoter holding of 59.58% and a public holding of 40.41%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 26 May 2023 | ₹1.60 M | Open |
Others Creation Date: 30 Sep 2022 | ₹6.84 M | Open |
Others Creation Date: 21 Sep 2022 | ₹6.60 M | Open |
How Many Employees Work at Fermenta Biotech?
Fermenta Biotech has a workforce of 327 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fermenta Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fermenta Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
